Sponsored By




Vote ReNetX Bio

for Venture




Erika R. Smith






ReNetX Bio


City/Town where Organization Located

New Haven


Company/organization description (<500 characters)

ReNetx Bio – a clinical stage company established to provide first-in-class therapeutics to treat damage to the central nervous system (CNS). The company's scientific founder, Dr. Stephen Strittmatter from Yale University, identified key factors that inhibit regrowth in the CNS. The company's novel protein therapeutic approach binds these inhibitors thereby enabling nerve fiber regrowth and increased synaptic plasticity for neural reconnection. ReNetX Bio has raised $25M, launched a Phase 1/2 clinical trial proof of concept trial and was granted "Fast Track Designation" from FDA.


Tell us about the milestones your venture accomplished in 2019, eg., key team members added, revenue level achieved, major sales made or endorsements received, successful exit, etc... (<500 characters)

Fast Track Designation, FDA approval and Launch of Clinical Trial Phase 1/2 study for spinal cord injury, License from major biotech


Stage: Does your venture generate revenue? YES or NO



What CT entrepreneur ecosystem resources (spaces, programs, events, schools, etc.) have helped you succeed? (<500 characters)

Yale, BioCT, Connecticut Innovations


What people are saying about ReNetX Bio...

 Changing lives through the REstoration of neural NETworks. Our mission is to provide first-in-class therapeutics to treat injury/damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI), stroke, and glaucoma. ?The company was founded based on the innovative technology from Dr. Stephen Strittmatter's work at Yale University to improve neurologic function after CNS injury – creating a significant and completely unmet need estimated at >$5B annually. The technology allows neurons to regrow by eliminating factors that inhibit growth. This technology platform could help to restore function in patients who are suffering from spinal cord injuries, stroke, and glaucoma.  

Bill Kenney





Others in this category


Atelier Cho Thompson


Aureus Tech Inc


Bare Life


Byrd's Books


Conscious Capital Wealth Management


Convexity Scientific




DICOM Director




Engagement Solutions


Enviro Power


Everything Bags inc


FinTron Invest


Framework Television


Geyser Remediation


Goat Boy Soaps


Green Check Verified


Green Home Solutions


Healthy PlanEat


Higher Education Literacy Professionals








Lactation Innovations


Land Maverick


Levo International


Litchfield Distillery




Nami Therapeutics


New London Main Street


Noteworthy Chocolates


Oma's Pride


Paul's Custom Pet Food LLC


Phoenix Tailings




Rafael Goldstein and Tyler Lederer-Plaskett


Raise Green


Ricker Duval


Roast Me


Rope Safe


SaniBrands, Inc.




Silver Fern Healthcare




Sound Affects








The Feel Good Lab


The Scoop Glastonbury


Therapeutic Bandage Products


Traveling Chic Boutique




Villarina's Pasta Shop



Escort Girl